MétaCan
Menu
Back to cohort
Record W4388597546 · doi:10.1016/j.rpth.2023.101187

PB0647 Life Expectancy and Mortality of Patients with Haemophilia A and Haemophilia B in Australia

2023· article· en· W4388597546 on OpenAlexaff
Sumit Parikh, Chin Wen Tan, Simon Brown, Chris Barnes, Stephanie P’ng, Tim Carter, Huyen Tran

Bibliographic record

VenueResearch and Practice in Thrombosis and Haemostasis · 2023
Typearticle
Languageen
FieldMedicine
TopicHemophilia Treatment and Research
Canadian institutionsSickKids FoundationHospital for Sick ChildrenUniversity of Toronto
Fundersnot available
KeywordsHaemophiliaLife expectancyMedicineHaemophilia AHaemophilia BPediatricsDemographyEnvironmental healthSociologyPopulation

Abstract

fetched live from OpenAlex

Background: Patients with severe haemophilia, characterised by baseline factor levels of less than 1%, represent approximately one-third of total haemophilia A (HA) and one-fifth of total haemophilia B (HB) population in Australia.Prescribing prophylaxis with regular infusions of the missing factor concentrate for such patients or more recently with non-factor replacement such as emcizumab is a well-established standard of care.However life expectancy and mortality remains unknown in this group.Aims: To assess impact of severity and prophylaxis on life expectancy, mortality in patients with HA and HB in Australia, develop survival models based on all-cause mortality and examine probability of survival by severity and treatment regimen.Methods: A national, retrospective study was conducted using data extracted from the Australian Bleeding Disorder Registry (ABDR).Data was obtained on severity, age, treatment regimen and mortality in patients with HA and HB.Patient demographics and results presented are based on ABDR data up until October 2022.Results: There are 2874 HA and 654 HB patients in the ABDR.All-cause mortality in HA accounted for 13.5%, 11.5% and 7.6% in severe, moderate and mild patients respectively.In HB, that was 11.7%, 5.4% and 9.8% in severe, moderate and mild patients respectively.Estimated median life expectancy is 79 years for HA and 82 years for HB patients, which is slightly lower than median life expectancy of general Australian population (83 years).Severity significantly impacts estimated median life expectancy, reducing to 72 years in severe HA and 68 years in severe HB.Prophylaxis favourably improved estimated median life expectancy to 78 years in severe HA, whereas reduced to 55 years in non-prophylaxis group.Conclusion(s): This study provides valuable insights of survival in patients with haemophilia in Australia.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.112
Threshold uncertainty score0.222

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.257
GPT teacher head0.476
Teacher spread0.220 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractno

Explore more

Same venueResearch and Practice in Thrombosis and HaemostasisSame topicHemophilia Treatment and ResearchFrench-language works237,207